Cycloplegic refraction in esotropic children. Cyclopentolate versus atropine

Area of Science:

• Ophthalmology
• Pediatric Optometry
• Clinical Refraction

Background:

• Esotropia in young children often involves hyperopia.
• Accurate refractive error assessment is crucial for managing esotropia.
• Cyclopentolate and atropine are commonly used cycloplegic agents.

Purpose of the Study:

• To compare the efficacy of atropine versus cyclopentolate in uncovering hyperopia in esotropic children.
• To determine if atropine cycloplegia is necessary for comprehensive hyperopia assessment in this population.

Main Methods:

• Retinoscopy was performed on esotropic children under 5.5 years old.
• Two cycloplegic agents were used: cyclopentolate 1% and atropine 1.0%.
• Hyperopic refractive errors were compared between the two agents.

Main Results:

• Atropine 1.0% revealed an average of +0.34 diopters more hyperopia than cyclopentolate 1.0%.
• 22% of children had 1.0 diopter or more of hyperopia uncovered by atropine.
• This significant subgroup often had initial cyclopentolate retinoscopy readings of +2.00 diopters or more.

Conclusions:

• Atropine cycloplegia is essential for uncovering the maximum hyperopic refractive error in young esotropic children.
• Routine atropine refraction is recommended for this patient group to ensure accurate diagnosis and treatment.
• The need for atropine may be more pronounced in children over 2 years old, though not statistically significant.